Atopic Dermatitis (AD) Clinical Trial
Official title:
A Phase 3, Multicenter, Open-label, Uncontrolled Trial to Evaluate the Efficacy and Safety of OPA-15406 Ointment in Infants Younger Than 2 Years of Age With Atopic Dermatitis
To investigate the efficacy of 0.3% OPA-15406 ointment when administered twice daily for 4 weeks in infants younger than 2 years of age with Atopic Dermatitis
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03151148 -
Targeted Microbiome Transplant in Atopic Dermatitis
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT05456529 -
Study of Ruxolitinib Cream in Adolescents With Atopic Dermatitis
|
Phase 3 | |
| Completed |
NCT04056130 -
A Study of Single and Multiple Ascending Doses of KBL697 in Healthy Subjects
|
Phase 1 | |
| Recruiting |
NCT04173442 -
Post-authorization Safety Study in North America to Monitor Pregnancy and Infant Outcomes Following Administration of Dupilumab During Planned or Unexpected Pregnancy
|
||
| Completed |
NCT03168113 -
Atopic Dermatitis (AD) and Food Allergy
|
N/A | |
| Terminated |
NCT03389893 -
Effect of Dupilumab (Anti-IL4Rα) on the Host-Microbe Interface in Atopic Dermatitis
|
Phase 4 | |
| Recruiting |
NCT04541810 -
A Study of Oral Upadacitinib (RINVOQ) Tablets to Assess Adverse Events and Change in Disease Symptoms in Korean Participants With Moderate to Severe Active Rheumatoid Arthritis, Atopic Dermatitis, Ankylosing Spondylitis or Psoriatic Arthritis
|
||
| Completed |
NCT02357940 -
Tolerance Evaluation of a Nighttime Moisturizing Balm on Babies and Adults With Eczema
|
N/A | |
| Recruiting |
NCT05667623 -
To Demonstrate the Superiority of IMP (1% OPA-15406 Ointment) to the Vehicle in Adult Patients With AD
|
Phase 3 | |
| Recruiting |
NCT05650320 -
To Demonstrate the Superiority of IMP (0.3% and 1% OPA-15406 Ointment) Versus the Vehicle in Pediatric Patients With AD
|
Phase 3 | |
| Completed |
NCT01979016 -
Study to Determine the Safety and Effectiveness of Dupilumab for Treatment of Atopic Dermatitis (AD)
|
Phase 2 | |
| Withdrawn |
NCT04666675 -
A Study of Oral Upadacitinib Tablets to Assess Change in Disease State in Participants Aged 12-75 Years With Moderate to Severe Atopic Dermatitis in Brazil
|
Phase 3 | |
| Active, not recruiting |
NCT05959083 -
Real World Study of Oral Upadacitinib Tablets to Assess Adverse Events and Change in Disease Activity in Adolescent and Adult Chinese Participants With Atopic Dermatitis
|
||
| No longer available |
NCT04159597 -
Expanded Access to Upadacitinib
|